# Nigel S. Cook

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nigel-s-cook/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,214 |
| Field | Ion channel regulation and function |
| h-index | 25 |
| i10-index | 47 |
| Last Known Institution | Novartis (Switzerland) |
| OpenAlex ID | https://openalex.org/A5002203402 |
| ORCID iD | 0000-0001-8211-7613 |
| Works | 74 |

## Researcher papers

- [The pharmacology of potassium channels and their therapeutic potential](https://scholariq.org/papers/the-pharmacology-of-potassium-channels-and-their-therapeutic-potential/)
- [Moving together: K+ channel openersand ATP-sensitive K+ channels](https://scholariq.org/papers/moving-together-k-channel-openersand-atp-sensitive-k-channels/)
- [In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.](https://scholariq.org/papers/in-vitro-and-in-vivo-comparison-of-two-k-channel-openers-diazoxide-and/)
- [Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile](https://scholariq.org/papers/synthetic-low-molecular-weight-thrombin-inhibitors-molecular-design-and/)
- [Effects of apamin, quinine and neuromuscular blockers on calcium‐activated potassium channels in guinea‐pig hepatocytes.](https://scholariq.org/papers/effects-of-apamin-quinine-and-neuromuscular-blockers-on-calcium-activated/)
- [Fibrinogen as a major risk factor in cardiovascular disease](https://scholariq.org/papers/fibrinogen-as-a-major-risk-factor-in-cardiovascular-disease/)
- [Potassium channels : structure, classification, function, and therapeutic potential](https://scholariq.org/papers/potassium-channels-structure-classification-function-and-therapeutic-potential/)
- [Giving Patients’ Preferences a Voice in Medical Treatment Life Cycle: The PREFER Public–Private Project](https://scholariq.org/papers/giving-patients-preferences-a-voice-in-medical-treatment-life-cycle-the-prefer/)
- [Similarities in the Mechanism of Action of Two New Vasodilator Drugs: Pinacidil and BRL 34915](https://scholariq.org/papers/similarities-in-the-mechanism-of-action-of-two-new-vasodilator-drugs-pinacidil/)
- [Mechanism of action and systemic and regional hemodynamics of the potassium channel activator BRL34915 and its enantiomers.](https://scholariq.org/papers/mechanism-of-action-and-systemic-and-regional-hemodynamics-of-the-potassium/)
- [Assessing Patient Preferences in Rare Diseases: Direct Preference Elicitation in the Rare Chronic Kidney Disease, Immunoglobulin A Nephropathy](https://scholariq.org/papers/assessing-patient-preferences-in-rare-diseases-direct-preference-elicitation-in/)

## Researcher topics

- [Ion channel regulation and function](https://scholariq.org/topics/ion-channel-regulation-and-function/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Respiratory and Cough-Related Research](https://scholariq.org/topics/respiratory-and-cough-related-research/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)

## Researcher university

- [Novartis (Switzerland)](https://scholariq.org/institutions/novartis-switzerland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.